Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,071 | 20,990 | 30,864 | 29,993 | 98,424 |
| Marketable Securities | 88,187 | 107,662 | 104,639 | 112,836 | 53,976 |
| Other current assets | 4,709 | 3,788 | 3,489 | 3,897 | 3,279 |
| TOTAL | $122,967 | $132,440 | $138,992 | $146,726 | $155,679 |
| Non-Current Assets | |||||
| PPE Net | 338 | 365 | 1,128 | 1,214 | 1,300 |
| Investments And Advances | 831 | 829 | 827 | 824 | 821 |
| Other Non-Current Assets | 8,786 | 9,376 | 16,786 | 17,621 | 18,445 |
| TOTAL | $9,955 | $10,570 | $18,741 | $19,659 | $20,566 |
| Total Assets | $132,922 | $143,010 | $157,733 | $166,385 | $176,245 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,969 | 579 | 975 | 771 | 2,628 |
| Accrued Expenses | 11,565 | 15,152 | 14,570 | 16,034 | 14,219 |
| TOTAL | $14,534 | $15,731 | $15,545 | $16,805 | $16,847 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 14,088 | 15,068 | 16,036 | 16,970 | 17,882 |
| TOTAL | $14,088 | $15,068 | $16,036 | $16,970 | $17,882 |
| Total Liabilities | $28,622 | $30,799 | $31,581 | $33,775 | $34,729 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,302 | 57,289 | 56,975 | 56,935 | 56,863 |
| Common Shares | 8 | 8 | 8 | 7 | 7 |
| Retained earnings | -473,776 | -464,740 | -449,624 | -441,126 | -430,565 |
| Other shareholders' equity | -36 | 101 | 142 | -25 | -19 |
| TOTAL | $104,300 | $112,211 | $126,152 | $132,610 | $141,516 |
| Total Liabilities And Equity | $132,922 | $143,010 | $157,733 | $166,385 | $176,245 |